Protein misfolding and aggregation: Mechanism, factors and detection

Process Biochemistry

Volumn 51, Issue 9, 2016, Pages 1183-1192

  Chaturvedi, Sumit Kumar ^a   Siddiqi, Mohammad Khursheed ^a   Alam, Parvez ^a   Khan, Rizwan Hasan ^a  

^a ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Amyloid fibril; Diseases; Protein aggregation; Protein misfolding

Indexed keywords

AGGREGATES; GLYCOPROTEINS; NEURODEGENERATIVE DISEASES; PROTEINS;

ALZHEIMER'S DISEASE; AMYLOID FIBRIL; FIBRILLAR STRUCTURES; MICROENVIRONMENTS; MODERN TECHNOLOGIES; PARKINSON'S DISEASE; PROTEIN AGGREGATION; PROTEIN MISFOLDING;

DISEASES;

EID: 84970003941     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2016.05.015     Document Type: Review

References (94)

1. [1] Blancas-Mejia, L.M., Ramirez-Alvarado, M., Systemic amyloidoses. Annu. Rev. Biochem. 82 (2013), 745–774.
2. [2] Hauser, C.A.E., Maurer-Stroh, S., Martins, I.C., Amyloid-based nanosensors and nanodevices. Chem. Soc. Rev. 43 (2014), 5326–5345.
3. [3] Ngoungoure, V.L.N., Schluesener, J., Moundipa, P.F., Schluesener, H., Natural polyphenols binding to amyloid: a broad class of compounds to treat different human amyloid diseases. Mol. Nutr. Food Res. 59 (2015), 8–20.
4. [4] Dobson, C.M., Principles of Protein Folding, Misfolding and Aggregation Seminars in Cell & Developmental Biology, 15, 2004, Elsevier, 3–16.
5. [5] Chothia, C., Lesk, A.M., The relation between the divergence of sequence and structure in proteins. EMBO J. 5 (1986), 823–826.
6. [6] Dobson, C.M., Protein folding and misfolding. Nature 426 (2003), 884–890.
7. [7] Hartl, F.U., Hayer-Hartl, M., Molecular chaperones in the cytosol: from nascent chain to folded protein. Science 295 (2002), 1852–1858.
8. [8] Goldberg, A.L., Protein degradation and protection against misfolded or damaged proteins. Nature 426 (2003), 895–899.
9. [9] Bukau, B., Weissman, J., Horwich, A., Molecular chaperones and protein quality control. Cell 125 (2006), 443–451.
10. [10] McClellan, A.J., Tam, S., Kaganovich, D., Frydman, J., Protein quality control: chaperones culling corrupt conformations. Nat. Cell Biol. 7 (2005), 736–741.
11. [11] Koo, E.H., Lansbury, P.T., Kelly, J.W., Amyloid diseases: abnormal protein aggregation in neurodegeneration. Proc. Natl. Acad. Sci. U. S. A. 96 (1999), 9989–9990.
12. [12] Evin, G., Beyreuther, K., Masters, C.L., Alzheimer's disease amyloid precursor protein (ApPP): proteolytic processing, secretases and βA4 amyloid production. Amyloid 1 (1994), 263–280.
13. [13] Castino, R., Lazzeri, G., Lenzi, P., Bellio, N., Follo, C., Ferrucci, M., Fornai, F., Isidoro, C., Suppression of autophagy precipitates neuronal cell death following low doses of methamphetamine. J. Neurochem. 106 (2008), 1426–1439.
14. [14] Ferrucci, M., Pasquali, L., Ruggieri, S., Paparelli, A., Fornai, F., alpha-synuclein and autophagy as common steps in neurodegeneration. Parkinsonism Relat. Disord. 14 (2008), 180–184.
15. [15] Isidoro, C., Biagioni, F., Giorgi, F.S., Fulceri, F., Paparelli, A., Fornai, F., Role of autophagy on the survival of dopamine neurons. Curr. Top. Med. Chem. 9 (2009), 869–879.
16. [16] Fornai, et al. Autophagy and amyotrophic lateral sclerosis: the multiple roles of lithium. Autophagy 4 (2008), 527–530.
17. [17] Fornai, F., Lenzi, P., Gesi, M., Soldani, P., Ferrucci, M., Lazzeri, G., Capobianco, L., Battaglia, G., De Blasi, A., Nicoletti, F., Paparelli, A., J. Neurochem. 88 (2004), 114–123.
18. [18] Lenzi, P., Fulceri, F., Lazzeri, G., Casini, A., Ruggieri, S., Paparelli, A., Fornai, F., Analysis of single, purified inclusions as a novel approach to understand methamphetamine neurotoxicity. Ann. N. Y. Acad. Sci. 1139 (2008), 186–190.
19. [19] Garcia-Pardo, J., Grana-Montes, R., Fernandez-Mendez, M., Ruyra, A., Roher, N., Aviles, F.X., Lorenzo, J., Ventura, S., Amyloid formation by human carboxypeptidase d transthyretin-like domain under physiological conditions. J. Biol. Chem. 289 (2014), 33783–33796.
20. [20] Eisenberg, D., Jucker, M., The amyloid state of proteins in human diseases. Cell 148 (2012), 1188–1203.
21. [21] Lee, C.F., Self-assembly of protein amyloids: a competition between amorphous and ordered aggregation. Phys. Rev. E, 80, 2009, 031922.
22. [22] Krebs, M.R., Devlin, G.L., Donald, A.M., Protein particulates: another generic form of protein aggregation. Biophys. J. 92 (2007), 1336–1342.
23. [23] Krebs, M.R.H., Devlin, G.L., Donald, A.M., Amyloid fibril-like structure underlies the aggregate structure across the pH range for beta-lactoglobulin. Biophys. J. 96 (2009), 5013–5019.
24. [24] Langkilde, A.E., Morris, K.L., Serpell, L.C., Svergun, D.I., Vestergaard, B., The architecture of amyloid-like peptide fibrils revealed by X-ray scattering, diffraction and electron microscopy. Acta Crystallogr. D Biol. Crystallogr. 71 (2015), 882–895.
25. [25] Wegner, A., Engel, J., Kinetics of the cooperative association of actin to actin filament. Biophys. Chem. 3 (1975), 215–225.
26. [26] Krebs, M.R.H., Wilkins, D.K., Chung, E.W., Pitkeathly, M.C., Chamberlain, A.K., Zurdo, J., Robinson, C.V., Dobson, C.M., Formation and seeding of amyloid fibrils from wild-type hen lysozyme and a peptide fragment from the β-domain. J. Mol. Biol. 300 (2000), 541–549.
27. [27] Colon, W., Kelly, J.W., Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31 (1992), 8654–8660.
28. [28] Chiti, F., Dobson, C.M., Amyloid formation by globular proteins under native conditions. Nat. Chem. Biol. 5 (2009), 15–22.
29. [29] Samuel, I.A.C., Sara, L., Leila, M.L., Erik, H., Duncan, A.W., Luke, R., Daniel, E.O., Michele, V., Christopher, M.D., Tuomas, P.J., Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. U. S. A. 24 (2013), 9758–9763.
30. [30] Barbu, E., Joly, M., The globular-fibrous protein transformation. Discuss. Faraday Soc. 13 (1953), 77–93.
31. [31] Reisler, E., Pouyet, J., Eisenberg, H., Molecular weights, association, and frictional resistance of bovine liver glutamate dehydrogenase at low concentrations Equilibrium and velocity sedimentation, light-scattering studies, and settling experiments with macroscopic models of the enzyme oligomer. Biochemistry 9 (1970), 3095–3102.
32. [32] Wegner, A., Engel, J., Kinetics of the cooperative association of actin to actin filament. Biophys. Chem. 3 (1975), 215–225.
33. [33] Firestone, M.P., de Levie, R., On one-dimensional nucleation and growth of living polymers I. Homogeneous nucleation. J. Theor. Biol. 104 (1983), 535–552.
34. [34] Prusiner, S.B., Molecular biology of prion diseases. Science 252 (1991), 1515–1522.
35. [35] Cohen, S.I.A., Linse, S., Luheshi, L.M., Hellstrand, E., White, D.A., Rajah, L., Otzen, D.E., Vendruscolo, M., Dobson, C.M., Knowles, T.P.J., Proliferation of amyloid-βα42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. U. S. A. 110 (2013), 9758–9763.
36. [36] Pekar, A.H., Frank, B.H., Conformation of proinsulin: a comparison of insulin and proinsulin self-association at neutral pH. Biochemistry 11 (1972), 4013–4016.
37. [37] Brems, D.N., Alter, L.A., Beckage, M.J., Chance, R.E., DiMarchi, R.D., Green, L.K., Long, H.B., Pekar, A.H., Shields, J.E., Frank, B.H., Altering the association properties of insulin by amino acid replacement. Protein Eng. 5 (1992), 527–533.
38. [38] Kendrick, B.S., Carpenter, J.F., Cleland, J.L., Randolph, T.W., A transient expansion of the native state precedes aggregation of recombinant human interferon-gamma. Proc. Natl. Acad. Sci. U. S. A. 95 (1998), 14142–14146.
39. [39] Krishnan, S., Chi, E.Y., Webb, J.N., Chang, B.S., Shan, D., Goldenberg, M., Manning, M.C., Randolph, T.W., Carpenter, J.F., Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. Biochemistry 41 (2002), 6422–6431.
40. [40] Raso, S.W., Abel, J., Barnes, J.M., Maloney, K.M., Pipes, G., Treuheit, M.J., King, J., Brems, D.N., Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci. 14 (2005), 2246–2257.
41. [41] Chi, E.Y., Krishnan, S., Randolph, T.W., Carpenter, J.F., Physical stability of proteins in aqueous solution: mechanism and driving forces in nonnative protein aggregation. Pharm. Res. 20 (2003), 1325–1336.
42. [42] Chi, E.Y., Weickmann, J., Carpenter, J.F., Manning, M.C., Randolph, T.W., Heterogeneous nucleation-controlled particulate formation of recombinant human platelet-activating factor acetylhydrolase in pharmaceutical formulation. J. Pharm. Sci. 94 (2005), 256–274.
43. [43] Rochet, J.C., Lansbury, P.T., Amyloid fibrillogenesis: themes and variations. Curr. Opin. Struct. Biol. 10 (2000), 60–68.
44. [44] Soto, C., Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 4 (2003), 49–60.
45. [45] Knowles, T.P.J., Vendruscolo, M., Dobson, C.M., The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 15 (2014), 384–396.
46. [46] Rosa, M., Bemporad, F., Pellegrino, S., Chiti, F., Bolognesi, M., Ricagno, S., Edge strand engineering prevents native-like aggregation in Sulfolobus solfataricus acylphosphatase. FEBS J. 281 (2014), 4072–4084.
47. [47] Fitzpatrick, A.W., Knowles, T.P.J., Waudby, C.A., Vendruscolo, M., Dobson, C.M., Inversion of the balance between hydrophobic and hydrogen bonding interactions in protein folding and aggregation. PLoS Comput. Biol., 7, 2011, e1002169.
48. [48] Kumar, V., Dixit, N., Zhou, L.L., Fraunhofer, W., Impact of short range hydrophobic interactions and long range electrostatic forces on the aggregation kinetics of a monoclonal antibody and a dual-variable domain immunoglobulin at low and high concentrations. Int. J. Pharm. 421 (2011), 82–93.
49. [49] Fodera, V., Zaccone, A., Lattuada, M., Donald, A.M., Electrostatics controls the formation of amyloid superstructures in protein aggregation. Phys. Rev. Lett., 111, 2013, 108105.
50. [50] Nilsson, M.R., Techniques to study amyloid fibril formation in vitro. Methods 34 (2004), 151–160.
51. [51] Xu, R., Particle Characterization: Light Scattering Methods, 13, 2001, Springer Science & Business Media, 1–399.
52. [52] Khurana, R., Gillespie, J.R., Talapatra, A., Minert, L.J., Ionescu-Zanetti, C., Millett, I., Fink, A.L., Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates. Biochemistry 40 (2001), 3525–3535.
53. [53] Tang, Y., Cohen, A.E., Enhanced enantioselectivity in excitation of chiral molecules by superchiral light. Science 332 (2011), 333–336.
54. [54] Alam, P., Rabbani, G., Badr, G., Badr, B.M., Khan, R.H., The surfactant-induced conformational and activity alterations in rhizopus niveus lipase. Cell Biochem. Biophys. 71 (2015), 1199–1206.
55. [55] Alam, P., Chaturvedi, S.K., Anwar, T., Siddiqi, M.K., Ajmal, M.R., Badr, G., Mahmoud, M.H., Hasan Khan, R., Biophysical and molecular docking insight into the interaction of cytosine β-D arabinofuranoside with human serum albumin. J. Lumin. 164 (2015), 123–130.
56. [56] Chaturvedi, S.K., Ahmad, E., Khan, J., Alam, P., Ishtikhar, M., Khan, R., Elucidating the interaction of limonene with bovine serum albumin: a multi-technique approach. Mol. Biosyst. 11 (2015), 307–316.
57. [57] Dusa, A., Kaylor, J., Edridge, S., Bodner, N., Hong, D.-P., Fink, A.L., Characterization of oligomers during α-synuclein aggregation using intrinsic tryptophan fluorescence. Biochemistry 45 (2006), 2752–2760.
58. [58] Dusa, A., Kaylor, J., Edridge, S., Bodner, N., Hong, D.-P., Fink, A.L., Characterization of oligomers during α-synuclein aggregation using intrinsic tryptophan fluorescence. Biochemistry 45 (2006), 2752–2760.
59. [59] Serno, T., Carpenter, J.F., Randolph, T.W., Winter, G., Inhibition of agitation-induced aggregation of an IgG-antibody by hydroxypropyl beta-cyclodextrin. J. Pharm. Sci. 99 (2010), 1193–1206.
60. [60] Chiti, F., Dobson, C.M., Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem 75 (2006), 333–366.
61. [61] Bozzola, J.J., Russell, L.D., Electron Microscopy: Principles and Techniques for Biologists. 1999, Jones & Bartlett Learning.
62. [62] Gregoire, S., Irwin, J., Kwon, I., Techniques for monitoring protein misfolding and aggregation in vitro and in living cells. Korean J. Chem. Eng. 29 (2012), 693–702.
63. [63] Muller, D.J., Dufrene, Y.F., Atomic force microscopy: a nanoscopic window on the cell surface. Trends Cell Biol. 21 (2011), 461–469.
64. [64] Hill, A.F., Barnham, K.J., Bottomley, S.P., Cappai, R., Gras, S., Waddington, L., Goldie, K., Transmission Electron Microscopy of Amyloid Fibrils Protein Folding, Misfolding, and Disease, 752, 2011, Humana Press, 197–214.
65. [65] Seiler, H., Secondary electron emission in the scanning electron microscope. J. Appl. Phys. 54 (1983), R1–R18.
66. [66] Hughes, L., Hawes, C., Monteith, S., Vaughan, S., Serial block face scanning electron microscopy- the future of cell ultrastructure imaging. Protoplasma 251 (2014), 395–401.
67. [67] Demeule Bl Gurny, R., Arvinte, T., Detection and characterization of protein aggregates by fluorescence microscopy. Int. J. Pharm. 329 (2007), 37–45.
68. [68] Hawe, A., Sutter, M., Jiskoot, W., Extrinsic fluorescent dyes as tools for protein characterization. Pharm. Res. 25 (2008), 1487–1499.
69. [69] Patil, S.M., Mehta, A., Jha, S., Alexandrescu, A.T., Heterogeneous amylin fibril growth mechanisms imaged by total internal reflection fluorescence microscopy. Biochemistry 50 (2011), 2808–2819.
70. [70] Conchillo-Sole, O., de Groot, N.S., Aviles, F.X., Vendrell, J., Daura, X., Ventura, S., AGGRESCAN: a server for the prediction and evaluation of. BMC Bioinf., 8, 2007, 65.
71. [71] Rojas Quijano, F.A., Morrow, D., Wise, B.M., Brancia, F.L., Goux, W.J., Prediction of nucleating sequences from amyloidogenic propensities of tau-related peptides. Biochemistry 45 (2006), 4638–4652.
72. [72] Trovato, A., Seno, F., Tosatto, S.C.E., The PASTA server for protein aggregation prediction. Protein Eng. Des. Sel. 20 (2007), 521–523.
73. [73] Hamodrakas, S.J., Protein aggregation and amyloid fibril formation prediction software from primary sequence: towards controlling the formation of bacterial inclusion bodies. FEBS J. 278 (2011), 2428–2435.
74. [74] Waltz, Oliveberg M., an exciting new move in amyloid prediction. Nat. Methods 7 (2010), 187–188.
75. [75] Tartaglia, G.G., Vendruscolo, M., The zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 37 (2008), 1395–1401.
76. [76] Alba, E., Busquets, M.A., Estelrich, J., Sabate, R., Predicting the aggregation propensity of prion sequences. Virus Res. 207 (2015), 127–135.
77. [77] Bryan, A.W. Jr., Menke, M., Cowen, L.J., Lindquist, S.L., Berger, B., BETASCAN: probable beta-amyloids identified by pairwise probabilistic analysis. PLoS Comput. Biol., 5, 2009, e1000333.
78. [78] Zambrano, R., Conchillo-Sole, O., Iglesias, V., Illa, R., Rousseau, F., Schymkowitz, J., Sabate, R., Daura, X., Ventura, S., PrionW: a server to identify proteins containing glutamine/asparagine rich prion-like domains and their amyloid cores. Nucleic Acids Res. 43 (2015), 331–337.
79. [79] Larsson, L.I., Immunocytochemistry: Theory and Practice. 1988, Taylor & Francis.
80. [80] Kebbel, A., Rocken, C., Immunohistochemical classification of amyloid in surgical pathology revisited. Am. J. Surg. Pathol. 30 (2006), 673–683.
81. [81] Schonland, S.O., Hegenbart, U., Bochtler, T., Mangatter, A., Hansberg, M., Ho, A.D., Lohse, P., Rocken, C., Immunohistochemistry in the classification of systemic forms of amyloidosis: a systematic investigation of 117 patients. Blood 119 (2012), 488–493.
82. [82] Baptista, F.I., Henriques, A.G., Silva, A.M.S., Wiltfang, J., da Cruz e Silva, O.A.B., Flavonoids as therapeutic compounds targeting key proteins involved in Alzheimer's disease. ACS Chem. Neurosci. 5 (2014), 83–92.
83. [83] Mansson, C., Kakkar, V., Monsellier, E., Sourigues, Y., Harmark, J., Kampinga, H.H., Melki, R., Emanuelsson, C., DNAJB6 is a peptide-binding chaperone which can suppress amyloid fibrillation of polyglutamine peptides at substoichiometric molar ratios. Cell Stress Chaperones 19 (2014), 227–239.
84. [84] Kook, S.Y., Lee, K.M., Kim, Y., Cha, M.Y., Kang, S., Baik, S.H., Lee, H., Park, R., Mook-Jung, I., High-dose of vitamin C supplementation reduces amyloid plaque burden and ameliorates pathological changes in the brain of 5XFAD mice. Cell Death Dis., 5, 2014, e1083.
85. [85] Stoilova, T., Colombo, L., Forloni, G., Tagliavini, F., Salmona, M., A new face for old antibiotics: tetracyclines in treatment of amyloidoses. J. Med. Chem. 56 (2013), 5987–6006.
86. [86] Palmal, S., Maity, A.R., Singh, B.K., Basu, S., Jana, N.R., Jana, N.R., Inhibition of amyloid fibril growth and dissolution of amyloid fibrils by curcumin-gold nanoparticles. Chem. A Eur. J. 20 (2014), 6184–6191.
87. [87] Chaturvedi, S.K., Zaidi, N., Alam, P., Khan, J.M., Qadeer, A., Siddique, I.A., Asmat, S., Zaidi, Y., Khan, R.H., Unraveling comparative anti-amyloidogenic behavior of pyrazinamide and D-cycloserine: a mechanistic biophysical insight. PLoS One, 10, 2015, e0136528.
88. [88] Chaturvedi, S.K., Alam, P., Khan, J.M., Siddiqui, M.K., Kalaiarasan, P., Subbarao, N., Ahmad, Z., Khan, R.H., Biophysical insight into the anti-amyloidogenic behavior of taurine. Int. J. Biol. Macromol. 80 (2015), 375–384.
89. [89] Abraham, J.N., Kedracki, D., Prado, E., Gourmel, C., Maroni, P., Nardin, C., Effect of the interaction of the amyloid beta (1-42) peptide with short single-stranded synthetic nucleotide sequences: morphological characterization of the inhibition of fibrils formation and fibrils disassembly. Biomacromolecules 15 (2014), 3253–3258.
90. [90] Lorenzo, A., Yankner, B.A., Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. U. S. A. 91 (1994), 12243–12247.
91. [91] Gordon, D.J., Sciarretta, K.L., Meredith, S.C., Inhibition of Beta-amyloid (40) fibrillogenesis and disassembly of beta-amyloid (40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues. Biochemistry 40 (2001), 8237–8245.
92. [92] Ignatova, Z., Gierasch, L.M., Inhibition of protein aggregation in vitro and in vivo by a natural osmoprotectant. Proc. Natl. Acad. Sci. U. S. A. 103 (2006), 13357–13361.
93. [93] Evans, C.G., Wisen, S., Gestwicki, J.E., Heat shock proteins 70 and 90 inhibit early stages of amyloid beta-(1-42) aggregation in vitro. J. Biol. Chem. 281 (2006), 33182–33191.
94. [94] Ikeda, K., Okada, T., Sawada S-i Akiyoshi, K., Matsuzaki, K., Inhibition of the formation of amyloid β-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett. 580 (2006), 6587–6595.